期刊文献+

妊娠期高血压疾病血浆GMP-140水平及Fg含量测定的临床意义 被引量:5

Measurement GMP-140 and Fg in patients with hypertensive disorders complicating pregnancy
原文传递
导出
摘要 目的探讨血栓前状态与妊娠期高血压疾病发生发展的关系。方法使用流式细胞术(FC)及PT-der法,测定2007年8月至2009年12月吉林大学第二医院及深圳市南山区妇幼保健院收治的妊娠期高血压疾病患者103例(研究组)和正常妊娠晚期孕妇30例(对照组)的产前、产后静脉血浆α-颗粒膜蛋白140(GMP-140)和纤维蛋白原(Fg)水平。将研究组的上述指标与对照组进行比较、将各组产前、产后指标进行比较。结果 GMP-140浓度子痫前期重度组与轻度组相比差异有统计学意义(P<0.05);与妊娠期高血压组及正常晚孕组相比差异有统计学意义(P<0.01)。子痫前期轻度组与正常晚孕组相比差异有统计学意义(P<0.05)。子痫前期重度组Fg含量与妊娠期高血压组相比差异有统计学意义(P<0.05);与正常晚孕组相比差异有统计学意义(P<0.01)。子痫前期重度组血浆GMP?140及Fg含量产后比产前增高,差异有统计学意义(P<0.05)。结论妊娠期高血压疾病患者存在血栓前状态,随妊娠期高血压疾病的病情加重血浆GMP-140水平及Fg含量逐渐增高,产后24小时内仍是血栓病的高发时期。 Objective To discuss the relationship between the pre-thrombotic state and the occurrence and development of hypertensive disorders complicating pregnancy. Methods The antepartum and postpartum von plasma platelet alpha granule membrane protein 140 and fibrinogen (Fg) were measured by flow cytometry and PT-der in 103 hypertensive disorders complicating pregnancy and 30 term pregnant women as controls. The outcomes of gestational hypertension group, mild-preeelampsia group, heavy-preeclampsia group were compared with that of control group. The antepartum and postpartum outcome of every group were compared. Results The levels of GMP-140 was different between heavy-preeclampsia group and that of mild -preeclampsia group ( P 〈 0.05 ). The levels of GMP-140 in heavy-preeclampsia group was higher obviously than that of the control group and the hypertensive disorders complicating pregnancy group( P 〈 0.01 ). The levels of GMP-140 was different between the mild -preeclampsia group and the control group( P 〈 0. 05 ). The levels of Fg was different between heavy-preeclampsia group and that of the hypertensive disorders complicating pregnancy group ( P 〈 0.05 ), was higher obviously than that of the control group ( P 〈 0.01 ). Significant positive relation exist between GMP-140 and Fg( P 〈0. 01 ). Significant positive relation exist between GMP-140 and Fg( P 〈 0. 01 ). The change between antepartum and postpartum:the GMP-140 and Fg level were obviously descend in heavy-preeclampsia(P 〈0.05 ). Conclusion There is increased markers of prothrombotic state in patients with hypertensive disorders complicating pregnancy. The amount of GMP-140 and Fg were higher as the bad condition. The time of 24 hours after birth was the period of high incidence of thrombosis.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第6期452-454,共3页 Chinese Journal of Practical Gynecology and Obstetrics
基金 深圳市南山区2008年科技计划项目(南卫2008027)
关键词 妊娠期高血压疾病 血栓前状态 血小板仪颗粒膜蛋白140 纤维蛋白原 hypertensive disorders complicating pregnancy prothrombotic state platelet alpha granule membrane proteinl40 fibrinogen
  • 相关文献

参考文献5

  • 1Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin [ J ]. J Am Acad Dermatol,2010,62 (4) :621-626.
  • 2刘兴德,魏云鸿.原发性高血压患者GMP-140的研究——附62例报告[J].新医学,2009,40(9):581-583. 被引量:5
  • 3Yoneyama Y, Suzuki S, Sawa R,et al. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia[ J]. Obstet Gynecol,2001,98 ( 2 ) :354-355.
  • 4郑媛媛,翟桂荣.子痫前期的凝血功能变化[J].北京医学,2007,29(4):238-240. 被引量:8
  • 5Nozawa T, Inoue H, Hirai T, et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation [ J ]. Int J Cardiol,2006, 109( 1 ) :59-65.

二级参考文献28

  • 1郭文年,张保军,修瑞霞.妊高征患者凝血及纤溶指标的变化及意义[J].山东医药,2004,44(21):50-50. 被引量:2
  • 2林其德.子癎前期及子的病因学研究进展[J].中国实用妇科与产科杂志,2006,22(1):3-5. 被引量:29
  • 3汪明灯,高修仁,梁鉴波.淋巴细胞镁含量与原发性高血压心、血管重构的相关研究[J].中山大学学报(医学科学版),2006,27(4):427-430. 被引量:4
  • 4LILLIE E O, O'CONNOR D T. Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity[J]. Hypertension, 2006, 47(3): 331-333.
  • 5BERGVALL N, ILIADOU A, JOHANSSON S, et al. Genetic and shared environmental factors do not confound the association between birth weight and hypertension: a study among Swedish twins[ J]. Circulation, 2007, 115 (23) : 2931-2938.
  • 6SCHILLACI G, PIRRO M, VAUDO G, et at. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension [ J ] . Hypertension, .9 2005, 45 (6) : 1078-1082.
  • 7SESSO H D, BURING J E, RIFAI N, et al. C-reactive protein and the risk of developing hypertension [ J ]. JAMA, 2003, 290 (22) : 2945-2951.
  • 8LI J J, FANG C H, HUI R T. Is hypertension an inflammatory disease? [J] Med Hypotheses, 2005, 64 (2): 236-240.
  • 9乐杰.妇产科学.6版.北京:人民卫生出版社,2005:110-117.
  • 10Tygart SG, Mc Royan DK, Spinnato JA, et al. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol,1986, 154:883 - 887.

共引文献10

同被引文献43

  • 1朱晓临,李保国,任琳.脑梗死患者急性期脂蛋白(a)和纤维蛋白原的变化[J].临床荟萃,2005,20(19):1096-1097. 被引量:13
  • 2李桂玲.妊娠期高血压疾病血脂代谢改变及临床意义的探讨[J].中国医药导报,2007,4(07Z):135-136. 被引量:12
  • 3Mayer EL, Jacbsen DW. Robinson K, et al. Homocysteine and cronary atheroslerosis[J]. Am Call Ca,dial, 1996, 27(3) : 518-520.
  • 4Saito K, Tobe T, Himoohima S, et al. Adiponecfine fl 64T mutation is associated with the metabolic syndrone and coronary artery diseases [J]. J Am Coll Cardiol, 2004, 43(7) :1195-1200.
  • 5Too JH, Park jE, Hong KP, et al. Moderate hyper homocy,teimcnia is associated with the presencc of coronary artery disea0es and the severity of coronerry atheroclerosis in Koreans [ J ]. Thromb Res, 1999, 94 ( 1 ) : 45 -48.
  • 6Amesen E, Rsfum H. Serum homocysteine and cor0nary heart dlsea- ses[J], hat Epidemiol, 1995, 124:704-705.
  • 7Toss H, Lindghl B, Siegbahn A, et al. Prognostic inteuence increased fibrinogen and C-reactive protein.levels in unstable artery diseases [J]. Circulation, 1997, 96: 4204-4205.
  • 8Takahashi H, Krita Y, Tamagata K, et al. Genemic structure andmutations in adipose-specific gene . Adiponecfin [ J ]. Int Obes Relat Metab Disord, 2000, 24: 861-863.
  • 9Dupouy D, Sie P, Dol F, et al. A Simple Method to Measure Dermatan Sulfate at Sub-Microgram Concentrations in Plasma [J]. Throbosis and Haemostasis,1988,60(2) :236-239.
  • 10Giri TK , Tollefsen DM. Placental dermatan sulfate: isolation, anticoagulant activity,and association with heparin cofactor II [J]. Blood,2006,107(7):2753-2758.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部